Enriched Pathway | Zone 1 | Zone 2 | Zone 3 | Zone 4 |
---|---|---|---|---|
Signal transduction | 40.6% | 21.1% | 9.3% | 16% |
Immune system | 33.6% | 16.2% | 8.4% | - |
MAPK signalling | 28.9% | 3.5% | - | - |
Pathways in cancer | 21.4% | 5.7% | - | - |
Disease | 21% | 10% | 7.2% | 9.8% |
Hemostasis | 16.5% | 6.9% | 3.3% | - |
Cell Cycle | 5.3% | 7.6% | 3.4% | - |
Gene expression | 7.2% | 7.5% | 8.7% | - |
Metabolism of proteins | - | 4.6% | 4.6% | - |